{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:41:21Z","timestamp":1790797281329,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T00:00:00Z","timestamp":1408492800000},"content-version":"vor","delay-in-days":353,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ajpath.2013.05.024","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T06:30:57Z","timestamp":1373956257000},"page":"938-950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Osteoprotegerin Contributes to the Metastatic Potential of Cells with a Dysfunctional TSC2 Tumor-Suppressor Gene"],"prefix":"10.1016","volume":"183","author":[{"given":"Wendy K.","family":"Steagall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Pacheco-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie G.","family":"Glasgow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.05.024_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin paracrine regulators of bone metabolism and vascular function","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib2","first-page":"345","article-title":"Receptor activator of nuclear factor-\u03baB ligand and osteoprotegerin: maintaining the balance to prevent bone loss","volume":"5","author":"Trouvin","year":"2010","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.ajpath.2013.05.024_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00198-009-0956-4","article-title":"Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures","volume":"21","author":"Jurado","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajpath.2013.05.024_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(08)60599-1","article-title":"Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study","volume":"371","author":"Richards","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2013.05.024_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1530\/JME-11-0067","article-title":"Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density","volume":"47","author":"Vidal","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib6","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMoa0801197","article-title":"Multiple genetic loci for bone mineral density and fractures","volume":"358","author":"Styrkarsdottir","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2013.05.024_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12020-012-9705-0","article-title":"Genotype-phenotype correlation in Juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene","volume":"42","author":"Brunetti","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.ajpath.2013.05.024_bib8","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2013.05.024_bib9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2013.05.024_bib10","article-title":"Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease","author":"Tousoulis","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib11","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2010.03.013","article-title":"Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity","volume":"55","author":"Venuraju","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increase serum concentrations in postmenopausal women with osteoporosis","volume":"14","author":"Yano","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2013.05.024_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4081\/ejh.2009.e3","article-title":"Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin","volume":"53","author":"Corallini","year":"2009","journal-title":"Eur J Histochem"},{"key":"10.1016\/j.ajpath.2013.05.024_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2353\/ajpath.2008.070395","article-title":"Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary artery hypertension","volume":"172","author":"Lawrie","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mvr.2008.06.004","article-title":"Role of \u03b1V integrin in osteoprotegerin-induced endothelial cell migration and proliferation","volume":"76","author":"Kobayashi-Sakamoto","year":"2008","journal-title":"Microvasc Res"},{"key":"10.1016\/j.ajpath.2013.05.024_bib16","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1210\/jc.2004-1895","article-title":"Syndecan-1 is involved in osteoprotegerin-induced chemotaxis in human peripheral blood monocytes","volume":"90","author":"Mosheimer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2013.05.024_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/CS20050175","article-title":"Role of osteoprotegerin (OPG) in cancer","volume":"110","author":"Holen","year":"2006","journal-title":"Clin Sci"},{"key":"10.1016\/j.ajpath.2013.05.024_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00018-008-8536-x","article-title":"Role of full-length osteoprotegerin in tumor cell biology","volume":"66","author":"Zauli","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajpath.2013.05.024_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/B:BREA.0000036900.48763.b3","article-title":"Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis","volume":"86","author":"Neville-Webbe","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2013.05.024_bib20","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1359\/JBMR.040703","article-title":"Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis","volume":"10","author":"Nyambo","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2013.05.024_bib21","first-page":"912","article-title":"Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand\/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells","volume":"63","author":"Shipman","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.05.024_bib22","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1158\/1078-0432.CCR-07-5019","article-title":"OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer","volume":"14","author":"De Toni","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2013.05.024_bib23","first-page":"1619","article-title":"Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells","volume":"62","author":"Holen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.05.024_bib24","first-page":"2306","article-title":"Serum osteoprotegerin levels in healthy controls and cancer patients","volume":"8","author":"Lipton","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2013.05.024_bib25","first-page":"2977","article-title":"Serum osteoprotegerin levels are increased in patients with advanced prostate cancer","volume":"10","author":"Brown","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2013.05.024_bib26","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.20550","article-title":"Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma","volume":"101","author":"Mizutani","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2013.05.024_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00428-003-0845-8","article-title":"Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma","volume":"443","author":"Ito","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ajpath.2013.05.024_bib28","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.C000290200","article-title":"Osteoprotegerin is an \u03b1v\u03b23-induced, NF-\u03ba\u0392-dependent survival factor for endothelial cells","volume":"275","author":"Malyankar","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2013.05.024_bib29","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/ijc.21606","article-title":"Osteoprotegerin (OPG): a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis","volume":"118","author":"Cross","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2013.05.024_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl","key":"10.1016\/j.ajpath.2013.05.024_bib31","first-page":"S49","article-title":"Clinical and molecular insights into lymphangioleiomyomatosis","volume":"22","author":"Steagall","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ajpath.2013.05.024_bib32","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2013.05.024_bib33","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.0407971101","article-title":"Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis","volume":"101","author":"Crooks","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2013.05.024_bib34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201003-0489OC","article-title":"Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis","volume":"182","author":"Cai","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2013.05.024_bib35","first-page":"1579","article-title":"Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA","volume":"143","author":"Adema","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/lrb.2009.0031","article-title":"Lymphangioleiomyomatosis and TSC2-\/- cells","volume":"8","author":"Darling","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1272\/jnms.67.311","article-title":"Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features","volume":"67","author":"Ferrans","year":"2000","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.ajpath.2013.05.024_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1165\/ajrcmb.21.3.3693","article-title":"Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis","volume":"21","author":"Matsumoto","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib39","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.1158\/0008-5472.CAN-07-1356","article-title":"TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis","volume":"67","author":"Pacheco-Rodriquez","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.05.024_bib40","doi-asserted-by":"crossref","first-page":"L64","DOI":"10.1152\/ajplung.00095.2010","article-title":"Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2","volume":"300","author":"Ikeda","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib41","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4049\/jimmunol.182.3.1270","article-title":"Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene","volume":"182","author":"Pacheco-Rodriguez","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-0-387-72009-8_2","article-title":"Ectodomain shedding of receptor activator of NF-kappaB ligand","volume":"602","author":"Hikita","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib43","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","article-title":"Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines","volume":"275","author":"Nakashima","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2013.05.024_bib44","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2013.05.024_bib45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s001980200045","article-title":"Correlates of osteoprotegerin levels in women and men","volume":"13","author":"Khosla","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajpath.2013.05.024_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cyto.2005.08.006","article-title":"Contribution of the familial and genetic factors on monocyte chemoattractant protein-1 variation in healthy human pedigrees","volume":"32","author":"Pantsulaia","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.ajpath.2013.05.024_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/hupa.2003.50","article-title":"Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis","volume":"34","author":"Bittmann","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib48","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangioleiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2013.05.024_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2009.01.011","article-title":"Mechanism of bone metastasis: the role of osteoprotegerin and of host-tissue microenvironment-related survival factors","volume":"283","author":"Fili","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2013.05.024_bib50","doi-asserted-by":"crossref","first-page":"e2338","DOI":"10.1371\/journal.pone.0002338","article-title":"A novel role for PECAM-1 (CD31) in regulating haematopoietic progenitor cell compartmentalization between the peripheral blood and bone marrow","volume":"3","author":"Ross","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2013.05.024_bib51","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2353\/ajpath.2009.080819","article-title":"Circulating monocytes expressing CD31 implications for acute and chronic angiogenesis","volume":"174","author":"Kim","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib52","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00000478-200109000-00007","article-title":"CD31 expression in intratumoral macrophages a potential diagnostic pitfall","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib53","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.5858\/2009-0576-RS.1","article-title":"Pulmonary lymphangioleiomyomatosis","volume":"134","author":"Zhang","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajpath.2013.05.024_bib54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9440(10)63843-6","article-title":"Renal angiomyolipomas from patients with sporadic lymphangioleiomyomatosis contain both neoplastic and non-neoplastic vascular structures","volume":"162","author":"Karbowniczek","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1165\/rcmb.2005-0387OC","article-title":"Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis","volume":"35","author":"Valencia","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2310\/6650.2001.33787","article-title":"Distribution and mRNA expression of insulin-like growth factor system in pulmonary lymphangioleiomyomatosis","volume":"49","author":"Valencia","year":"2001","journal-title":"J Investig Med"},{"key":"10.1016\/j.ajpath.2013.05.024_bib57","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0002-9440(10)61198-4","article-title":"Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma","volume":"167","author":"Lesma","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib58","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.febslet.2012.05.037","article-title":"Syndecans play dual roles as cell adhesion receptors and docking receptors","volume":"586","author":"Kwon","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ajpath.2013.05.024_bib59","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/jcp.20354","article-title":"Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor","volume":"204","author":"Zannettino","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/lrb.2009.0020","article-title":"mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the \u201cperfect storm\u201d of pro-metastatic factors in LAM pathogenesis","volume":"8","author":"Yu","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.ajpath.2013.05.024_bib61","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2003-10-3380","article-title":"17\u03b2-Estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived cells","volume":"104","author":"Bengtsson","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2013.05.024_bib62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1164\/rccm.200406-701OC","article-title":"Bone mineral density in lymphangioleiomyomatosis","volume":"171","author":"Taveira-DaSilva","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2013.05.024_bib63","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1378\/chest.07-1205","article-title":"Pulmonary artery pressure in lymphangioleiomyomatosis","volume":"132","author":"Taveira-DaSilva","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ajpath.2013.05.024_bib64","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S8756-3282(03)00090-5","article-title":"Serum levels of osteoprotegerin increase with age in a healthy adult population","volume":"32","author":"Kudlacek","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2013.05.024_bib65","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s10354-010-0818-x","article-title":"Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help?","volume":"160","author":"Wagner","year":"2010","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ajpath.2013.05.024_bib66","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1476-4598-8-49","article-title":"Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact","volume":"8","author":"Reid","year":"2009","journal-title":"Mol Cancer"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013004148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013004148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:42:52Z","timestamp":1757601772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013004148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0002944013004148"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.05.024","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoprotegerin Contributes to the Metastatic Potential of Cells with a Dysfunctional TSC2 Tumor-Suppressor Gene","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}